Prøve GULL - Gratis
How AI is enhancing medical diagnostics
Bio Spectrum
|BioSpectrum India June 2025
India's medical diagnostics sector is undergoing a transformative shift, fuelled by the power of Artificial Intelligence (AI). According to a report by Research and Markets, the AI-based Medical Diagnostics Market in India was valued at $12.87 million in 2024 and is projected to soar to $44.87 million by 2030, growing at an impressive CAGR of 23.1 per cent.

However, the rapid adoption of AI technologies in diagnostics is probably more focused on early detection of diseases such as cancer, respiratory diseases, diabetes, and cardiovascular diseases, among others. Sensing this bend, the industry has now started deploying AI to detect unexplored areas such as ophthalmology, dermatology, trichology, in vitro fertilisation, to name a few. Let's find out more about the potential that lies in the hands of AI in medical diagnostics.
AI is rapidly transforming healthcare, particularly in diagnostics and imaging across the globe. The industry is continuously developing solutions in the form of new apps and devices using AI to ease out the burden on the healthcare setting. As a result, these solutions are improving diagnostic accuracy and enabling faster treatment decisions for conditions such as cancer, tuberculosis, diabetes, cardiovascular diseases etc.
With India witnessing a rising burden of these diseases, coupled with a shortage of skilled healthcare professionals, AI-driven diagnostic solutions are emerging as a transformative force. By reducing diagnostic turnaround times, increasing accuracy, and enabling remote healthcare access, AI is playing a pivotal role in addressing the growing healthcare demand and disease burden, particularly in urban areas where non-communicable diseases (NCDs) are more prevalent.
However, challenges persist in terms of high implementation costs, the lack of standardised AI regulations, a limited skilled workforce and concerns over data privacy and patient confidentiality. Furthermore, limited adoption of AI in rural healthcare facilities remains a significant barrier to widespread deployment in India.
Despite these challenges, many new areas such as ophthalmology, dermatology, trichology, in vitro fertilisation, etc. are being touched upon by the industry where the use of AI can offer timely diagnosis and effective treatment plans.
Denne historien er fra BioSpectrum India June 2025-utgaven av Bio Spectrum.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum
WHO certifies Suriname malaria-free
Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).
1 min
August 2025

Bio Spectrum
Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation
Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.
1 min
August 2025
Bio Spectrum
Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab
Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.
1 min
August 2025
Bio Spectrum
Illumina buys SomaLogic for $425 M to accelerate proteomics business
Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.
1 min
August 2025

Bio Spectrum
Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26
Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.
1 min
August 2025
Bio Spectrum
WHO highlights risks associated with use of semaglutide medicines
The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.
1 min
August 2025

Bio Spectrum
Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin
Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.
1 min
August 2025

Bio Spectrum
AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru
AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.
1 min
August 2025

Bio Spectrum
Novo Nordisk launches injectable Semaglutide for weight management in India
Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.
1 min
August 2025

Bio Spectrum
Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?
India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.
12 mins
August 2025
Listen
Translate
Change font size